ГоловнаArchive of numbers2022Volume 30, issue 3 (112)Clinical and pathogenetic patterns of the occurrence of somatic disorders in patients with delirium tremens
Title of the article Clinical and pathogenetic patterns of the occurrence of somatic disorders in patients with delirium tremens
Authors Zadorozhnyi Volodymyr
Linskiy Igor
In the section DIAGNOSTICS AND THERAPY OF NEUROLOGICAL, MENTAL AND NARCOLOGICAL DISORDERS
Year 2022 Issue Volume 30, issue 3 (112) Pages 98-104
Type of article Scientific article Index UDK 616.853.-008.441.13-06 Index BBK -
Abstract DOI: https://doi.org/10.36927/2079-0325-V30-is3-2022-91
The aim of the study was to study in patients with delirium tremens (DT) changes in the content of non-ionic osmotically active substances in the blood serum, namely the total concentration of glucose and urea, depending on the presence and number of somatic complications. A total of 570 men with DT were included in the study. The age of the patients ranged from 18 to 68 years. In 54 patients, a state of alcohol withdrawal with severe somatovegetative manifestations (diagnosis code F10.3 according to ICD-10) was stated, in 211 people — the presence of “classic” DT (F10.4), and in 305 patients — different variants of severe DT (F10.43). All patients were divided into 4 groups. Observation group 1 consisted of 222 people with DT, whose mental illness was not accompanied by the development of somatic complications. Group 2 included 193 patients with DT, who had one somatic complication during their illness. Observation group 3 consisted of 104 patients who had two somatic complica- tions. Group 4 included 51 patients with DT, each of whom had three or four somatic complications. Four types of somatic complications were taken into account: impaired liver function; impaired renal function; development of acute pneumonia; the development of acute pancreatitis. We were able to mathematically describe a previously unknown relationship between the level of osmoticity caused by non-ionic osmotically active substances in blood serum and the number of somatic complications in patients with DT. It is expressed by the following formula: Ur + Gl = 1 mmol/l (1.79N + 9.97), where: Ur is the concentration of urea in blood serum, mmol/l; Gl is the concentration of glucose in the blood serum, mmol/l; Ur + Gl — concentration of non-ionic osmoti- cally active substances in blood serum, mmol/l; 1,79 — dimensionless proportionality factor; N is the number of somatic complications in one patient, a dimensionless value; 1 mmol/l — the coefficient necessary to comply with the dimensions of the left and right parts of the formula; 9.97 is a constant, the size of which depends on the chosen system of units. It has been shown that somatic complications take the second place among the clinical manifestations (after indicators of the severity of the mental status) in terms of their impact on the survival of patients with DT.
Key words delirium tremens, non-ionic osmotically active substances in blood serum, blood glucose, blood urea, somatic complications
Access to full text version of the article pdf download
Bibliography 1. Wojnar, M., Bizoń, Z. and Wasilewski, D. (1999), The Role of Somatic Disorders and Physical Injury in the Development and Course of Alcohol Withdrawal Delirium. Alcoholism: Clinical and Experimental Research, 23: 209-213. https://doi. org/10.1111/j.1530-0277.1999.tb04101.x. 2. Mayo-Smith MF, Beecher LH, Fischer TL et al. Management of alcohol withdrawal delirium. An evidence-based practice guideline. Arch Intern Med. 2004; 164: 1405-12. 3. Grover S, Ghosh A. Delirium Tremens: Assessment and Management. J Clin Exp Hepatol. 2018 Dec; 8(4): 460-470. doi: 10.1016/j.jceh.2018.04.012. 4. Kurzemnieks, K. (2021). Analysis of risk factors in pa- tients with alcohol delirium who have been treated at the riga psychiatry and narcology center in 2018. European Psychiatry, 64(S1), S819-S819. doi: 10.1192/j.eurpsy.2021.2165. 5. Rahman A, Paul M. Delirium Tremens. [Updated 2021 Aug 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan. Available from: https://www.ncbi.nlm. nih.gov/books/NBK482134/. 6. Leggio L, Ray LA, Kenna GA, Swift RM. Blood glucose level, alcohol heavy drinking, and alcohol craving during treatment for alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alco- hol Dependence (COMBINE) Study. Alcohol Clin Exp Res. 2009 Sep;33(9):1539-44. DOI: 10.1111/j.1530-0277.2009.00982.x. 7. Pach D, Radomska M, Groszek B, Hydzik P, Gilis-Janusze- wska A, Pach J. Abnormal glucose metabolism in men with alcohol withdrawal syndrome. Przegl Lek. 2014; 71(9): 469-74. PMID: 25632784. 8. Chandini S, Sequeira AZ, Mathai P J. Factors associated with delirium tremens: A retrospective chart study. Muller Journal of Medical Sciences and Research. 2013; 4 (2): 86-9. DOI: 10.4103/0975-9727.118234. 9. Dobrzański T, Pieschl D. Plasma immunoreactive insulin and somatotropin in delirium tremens and alcoholic halluci- nosis. J Stud Alcohol. 1976 Mar;37(3):327-33. doi: 10.15288/ jsa.1976.37.327. 10. Sivolap Yu. P., Savchenkov V. A. ; pod red. N. M. Zharikova. Farmakoterapiya v narkologii. Moskva : Medicina, 2000. 352 s. 11. Trzepacz P. T., Baker R. W., Greenhouse J. A symptom rating scale for delirium. Psychiatry Res. 1988 Jan; 23(1): 89- 97. PMID: 3363018. 12. Validation of the Delirium Rating Scale-Revised-98: comparison with the delirium rating scale and the cognitive test for delirium / Trzepacz P. T., Mittal D., Torres R. [et al.]. J Neuropsychiatry Clin Neurosci. 2001 Spring; 13(2): 229-42. DOI: 10.1176/jnp.13.2.229. 13. Zadorozhny’j V. V. Shkala ocenki dlitel’nosti alkogol’nogo deliriya. U zb.: Materialy XVIII Ukrainskoi nauk.-prakt. konf. “Dovzhenkivski chytannia”. Kharkiv : Pleiada, 2018. S. 51—52. 14. Men’shikov V. V. Laboratorny’e metody’ issledovaniya v klinike : spravochnik. Moskva : Medicina, 1987. 368 s. 15. Magarian GJ, Lucas LM, Kumar KL. Clinical significance in alcoholic patients of commonly encountered laboratory test results. West J Med. 1992 Mar; 156(3): 287-94. PMID: 1595246. 16. Koryachkin V. A., Strashnov V. I., Chufarov V. N. Klinicheskie funkcional’ny’e i laboratorny’e testy’ v anesteziologii i intensivnoj terapii : rukovodstvo. SPb. : S.-Peterburg. med. izd-vo, 2001. S. 73. 17. Møller F. Veronalbehandling af delirium tremens. Ugeskr Laeger. 1978; 71: 1253-9. 18. Kramp P, Rafaelsen OJ. Delirium tremens: a double-blind comparison of diazepam and barbital treatment. Acta Psychiatr Scand 1978; 58: 174-90. 19. Woo E, Greenblatt DJ. Massive benzodiazepine require- ments during acute alcohol withdrawal. Am J Psychiatry. 1979; 136: 821-3. 20. Hemmingsen R, Kramp P. Delirium tremens and related clinical states: psychopathology, cerebral pathophysiology and psychochemistry: a two-component hypothesis concerning etiology and pathogenesis. Acta Psychiatr Scand Suppl. 1988; 345: 94-107. PMID: 3067544. 21. Pycha R, Miller C, Barnas C, Hummer M, Stuppäck C, Whitworth A, Fleischhacker WW. Intravenous flunitrazepam in the treatment of alcohol withdrawal delirium. Alcohol Clin Exp Res. 1993; 17: 753-7. doi: 10.1111/j.1530-0277.1993.tb00835.x. 22. Hack JB, Hoffmann RS, Nelson LS. Resistant alcohol withdrawal: does an unexpectedly large sedative requirement identify these patients early? J Med Toxicol. 2006;2:55-60. doi: 10.1007/BF03161171. 23. Gold JA, Rimal B, Nolan, Nelson LS. A strategy of escalat- ing doses of benzodiazepines and phenobarbital administra- tion reduces the need for mechanical ventilation in delirium tremens. Crit Care Med. 2007; 35: 724-30. doi: 10.1097/01. CCM.0000256841.28351.80.